Azetidinone–retinoid hybrids: Synthesis and differentiative effects
As a part of a systematic investigation on the synthesis and biological activities of new β-lactam compounds, we examined β-lactam candidates 1, 2E and 2Z and their ability to induce cell proliferation or differentiation. Azetidinone 1 was chosen for its activity (previously evaluated) as selective...
Saved in:
Published in | European journal of medicinal chemistry Vol. 70; pp. 857 - 863 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
ISSY-LES-MOULINEAUX
Elsevier Masson SAS
01.12.2013
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | As a part of a systematic investigation on the synthesis and biological activities of new β-lactam compounds, we examined β-lactam candidates 1, 2E and 2Z and their ability to induce cell proliferation or differentiation. Azetidinone 1 was chosen for its activity (previously evaluated) as selective HDAC8 inhibitor, whereas β-lactams 2E and 2Z were designed to have a hybrid retinoid-azetidinone structure, de novo synthesized and fully characterized. Biological activities were determined in cellular assays on neuroblastoma cells SH-SY5Y. Azetidinone 1, 2E and 2Z led to a moderate effect in decreasing SH-SY5Y cell proliferation and β-lactams 2E and 2Z induced an early stage differentiation.
The present results uncovered a new role of specifically designed β-lactam compounds in epigenetic regulation.
[Display omitted]
•Synthesis of new β-lactam retinoid–azetidinone hybrids were reported.•Three azetidinone molecules were evaluated on neuroblastoma cells.•Differentiative effects were evaluated. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/j.ejmech.2013.09.057 |